Latest News for: granulocytes

Edit

Cancer Supportive Drugs Market Updates : Granulocyte Colony-Stimulating Factors To Maintain Its Lead During 2023-2032

MENA FN 19 Jul 2024
(MENAFN - EIN Presswire) Cancer Supportive Care Drugs Market The cancer supportive care drugs market is estimated to reach $25 billion by 2032, growing at a CAGR of 2% from 2023 to 2032. On the ... .
Edit

Beyondspring Presents New Clinical Evidence Of Plinabulin Protection Of Granulocyte-Monocyte Progenitor Stem Cells For The ...

MENA FN 13 Sep 2022
(MENAFN - GlobeNewsWire - Nasdaq) NEW YORK, Sept. 13, 2022 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the–Company– or–BeyondSpring–) (NASDAQ. BYSI), a clinical stage global biopharmaceutical company ... .
Edit

BeyondSpring Presents New Clinical Evidence of Plinabulin Protection of Granulocyte-Monocyte Progenitor Stem Cells for the Prevention of Chemotherapy-Induced Neutropenia at the ESMO Congress 2022 (BeyondSpring Inc)

Public Technologies 13 Sep 2022
) Plinabulin rapidly (within 24 hours) mitigates chemotherapy-induced myelosuppression by protecting bone marrow granulocyte-monocyte progenitor (GMP) stem cells.
Edit

Granulocyte-Colony Stimulating Factor Market Increased Research Activities Boost Demand Opportunities

MENA FN 27 Jul 2022
(MENAFN - EIN Presswire) Granulocyte-colony stimulating factor market provides an in-depth analysis with the current trends and future estimations. PORTLAND, OREGON, UNITED STATES, July 27, 2022 ... .
  • 1

Most Viewed

×